Posts by Sandra Ansanay-Alex
Bruker expands its collaboration with Atinary and makes a minority investment
Bruker Corporation (NASDAQ:BRKR) announced that it is expanding its strategic collaboration with Atinary Technologies Inc., and acquiring a minority stake in the Lausanne-based company. The financial terms of the deal were not disclosed, according to the press release. This collaboration aims to integrate Chemspeed’s laboratory automation platforms, Bruker’s analytical instruments and SciY’s scientific software into…
Read MoreSwiss Gender Medicine Symposium
The Swiss Gender Medicine Symposium is taking place on 26 and 27 October 2026 at the Kursaal Bern Gender medicine has long since answered the question of whether biological sex and gender play a role. The evidence is there. What remains is the more difficult task: translating this knowledge into clinical practice, research structures, and…
Read MoreAlcon Halts Intraocular Lens Programmes After $402 Million Writedown
Alcon, the Geneva-based global leader in eye care, announced on Monday evening that it is discontinuing its intraocular lens (IOL) programmes, technology it acquired through the 2019 purchase of PowerVision for $285 million. These lenses were primarily designed for use in cataract surgery, replacing the eye’s clouded natural lens. Alcon has its global headquarters in…
Read MoreSICTIC Investors Day at FONGIT
The SICTIC Investor Day at Fongit is taking place on 24 September 2026 in Plan-les-Ouates. On 24 September 2026, join SICTIC at FONGIT in Geneva for an Investor Day, where groundbreaking startups meet forward-thinking investors. This event, hosted at Geneva’s premier innovation incubator, is ideal for those looking to discover new ideas and network with…
Read MoreEureka Biotech
Apply before 25 September 2026 for the Eureka Biotech programme, in collaboration with Innosuisse Project applications with a clear innovation content and implementation plan in biotech areas like medicine, bioinformatics, pharmaceutical products and services, life sciences, digitalization, (bio)process technology (non-exhaustive list of cooperation areas) are welcome. Check call outline for topics and scope. The countries…
Read MoreOculis Secures FDA Backing and Full Ownership of Privosegtor
Oculis Holding AG, a Zug-based biopharmaceutical company with operations in Lausanne, has had a decisive first two weeks of August 2026, combining positive US regulatory feedback with a strategic acquisition that together strengthen its position in neuro-ophthalmology. Positive FDA pre-IND feedback for acute MS relapses On August 3, Oculis announced that the FDA’s Division of…
Read MoreHealth VC Summit
Health VC Summit is taking place from 2 to 3 September in Zürich. The events brings together three regions: China, Saudi Arabia and Europe. Europe, China, and Saudi Arabia are shaping the next chapter of healthcare investment. HealthVC Summit 2026 brings these three innovation ecosystems together in Zurich for two days focused on cross-border investment,…
Read MorePitch Contest – Foire du Valais
Apply before 7 September 2026 for the Foire du Valais Pitch Contest organised by The Ark. The call for project is for Valais-based projects only. The Foire du Valais Pitch Contest returns in 2026. Organised by The Ark Incubator, it offers young Valais-based startups the chance to present their project to a wide audience, gain…
Read MoreEPFL Investors Day – Call for Project
Apply before 31 August 2026 for the EPFL Investors Day, and pitch at one of Switzerland’s largest investment event EPFL Startup is now accepting applications for EPFL Investor Day 2026, which brings together leading investors and groundbreaking deep-tech start-ups. Entrepreneurs in Western Switzerland who are preparing to raise funds or are currently in the process…
Read MoreAO Innovation Funding
Apply before 31 August of the last day of February, each year. AO Foundation supports innovations that address unmet clinical needs in musculoskeletal care through its AO Innovation Funding. Selected startups receive customized funding, expert mentorship, and access to the world’s largest network of orthopedic surgeons, who validate and use the innovations in practice. Criteria…
Read More